March 2012
Volume 53, Issue 14
Free
ARVO Annual Meeting Abstract  |   March 2012
Periocular Tissue Concentration of Propranolol after Delivery with a Gel-forming Solution
Author Affiliations & Notes
  • Michael B. Yang
    Abrahmson Pediatric Eye Institute/Ophthalmology, Cincinnati Children's Hospital, College of Medicine,
    University of Cincinnati, Cincinnati, Ohio
  • Jinsong Hao
    Division of Pharmaceutical Sciences/Winkle College of Pharmacy,
    University of Cincinnati, Cincinnati, Ohio
  • Hongzhou Liu
    Division of Pharmaceutical Sciences/Winkle College of Pharmacy,
    University of Cincinnati, Cincinnati, Ohio
  • S Kevin Li
    Division of Pharmaceutical Sciences/Winkle College of Pharmacy,
    University of Cincinnati, Cincinnati, Ohio
  • Footnotes
    Commercial Relationships  Michael B. Yang, None; Jinsong Hao, None; Hongzhou Liu, None; S Kevin Li, Aciont (C)
  • Footnotes
    Support  Unrestricted Grant from Research to Prevent Blindness (to James J. Augsburger, chairman), Faculty Research Grant to J. Hao (University of Cincinnati College of Pharmacy)
Investigative Ophthalmology & Visual Science March 2012, Vol.53, 6872. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Michael B. Yang, Jinsong Hao, Hongzhou Liu, S Kevin Li; Periocular Tissue Concentration of Propranolol after Delivery with a Gel-forming Solution. Invest. Ophthalmol. Vis. Sci. 2012;53(14):6872.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose: : Oral propranolol is an effective treatment for periocular infantile capillary hemangiomas (ICH). We previously reported higher concentrations of propranolol in periocular tissues and lower peripheral blood levels of drug after topical, ocular instillation of propranolol as compared with oral delivery (Hao et al 2011). The delivery of propranolol in a gel-forming solution (GFS) may further increase the local tissue concentration of propranolol while decreasing systemic exposure to the drug as compared with a non-GFS. We compared the periocular tissue concentration and plasma concentration of propranolol after ocular instillation of propranolol 0.5% in GFS and in non-GFS

Methods: : Propranolol was delivered by topical, ocular instillation of 0.15 ml (50 μl x 3 doses) of propranolol (0.5%) in phosphate buffered saline solution or propranolol (0.5%) in 1% sodium alginate gel-forming solution (GFS) for total of 0.75 mg in the treated eye of New Zealand male white rabbits (2 to 2.5 kg body weight). Rabbits were sacrificed at 1, 4, 8 and 24 hours after drug instillation. HPLC was used to analyze peripheral blood and periocular tissues, which were dissected and separately analyzed as upper lid inner, upper lid outer, lower lid inner, and lower lid outer layers; bulbar conjunctiva; superior rectus and oblique; inferior rectus and oblique; medial and lateral rectus; and periocular fat. Peripheral blood samples were also analyzed by HPLC.

Results: : At 1 h post dosing, propranolol in GFS resulted in similar or higher concentrations of propranolol in most periocular tissues (except inferior rectus and oblique) as compared with propranolol in non-GFS. By 8 h, most tissue types had higher concentrations of drug in the GFS group. The plasma concentration of drug was lower in the GFS group at 1h, and both GFS and non-GFS groups had undetectable drug levels in plasma by 4 to 8 h.

Conclusions: : Ocular delivery of propranolol in a GFS resulted in similar or higher concentration of propranolol in most periocular tissues as compared to non-GFS. The finding of higher tissue concentrations with GFS may be due to prolonged retention of drug on, and decreased clearance of the drug from, the ocular surface. Lower systemic exposure to propranolol when using GFS may decrease the risk of systemic side effects from the drug.

Keywords: drug toxicity/drug effects • tumors 
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×